- Case Report
- Open Access
Over-expression of glutamine synthase in focal nodular hyperplasia (part 1): Early stages in the formation support the hypothesis of a focal hyper-arterialisation with venous (portal and hepatic) and biliary damage
© Bioulac-Sage et al; licensee BioMed Central Ltd. 2008
- Received: 19 October 2007
- Accepted: 29 February 2008
- Published: 29 February 2008
Most focal nodular hyperplasia (FNH) cases are diagnosed by chance. We studied a case of pre-FNH. We used glutamine synthase as an immunohistochemical marker for perivenous zones.
Neither fibrotic scars nor hepatocytic nodules surrounded by fibrosis with a ductular reaction were observed in the sections studied. Most sections generally displayed preserved architecture. The glutamine synthase-positive hepatocyte areas were wider than those observed in non-tumoural surrounding liver, and they tended to extend outwards. Portal tracts bordering the nodule were more fibrotic, with an absence of portal veins and ducts and with arterial proliferation often in proximity with large draining veins; isolated arteries were present and hepatic veins were rare in the nodule. These features appeared prior to the identification of other major criteria characteristics of FNH, thus supporting the "hypothesis of Wanless".
The findings confirm that in FNH there is a portal tract injury leading to local portal vein injury. This leads to a cascade of events, including arterial venous shunts, ductular reaction, and scar formation.
- Hepatic Vein
- Hepatic Stellate Cell
- Focal Nodular Hyperplasia
- Portal Tract
- Venous Shunt
The estimated prevalence of focal nodular hyperplasia(FNH) is 0.4 to 3% in a non-selected autopsy series and 0.3% in a clinical series. Most FNH cases are diagnosed by chance, but some are symptomatic. In contrast to hepatocellular adenomas, imaging techniques are sufficient for diagnosis in 70% of FNH cases. Histopathological examination is required for diagnosis in the few cases that have non-diagnostic imaging features [1, 2]. In about two-thirds of cases, the FNH lesion is solitary. The typical histopathological features of classic FNH include a firm, well-delimited but not encapsulated lesion composed of hepatocellular nodules, a central scar, and radiating fibrous cords. The fibrous regions typically contain large dystrophic arteries and ductular reaction, usually associated with a lymphocytic infiltrate. FNH can be diagnosed from a liver biopsy. However, in some cases of FNH, the histopathological diagnosis may still be difficult, even in a resected specimen; this is because the definitive histopathological features may be absent, inconspicuous, or atypical. FNH can be associated with vascular abnormalities, including hepatic hemangiomas, which support vascular involvement in the pathogenesis of this lesion [3, 4]. FNH has also been reported in patients with a variety of non-hepatic tumours and tumour-like conditions .
Recently, Wanless et al. hypothesized that the primary lesion of FNH is the result of a portal tract injury leading to injury of the local portal vein (PV) with secondary large arterial-PV shunts . We studied the early stages of FNH formation to help validate this hypothesis. Thus, we reviewed a pre-FNH case previously published , taking advantage of glutamine synthase (GS) staining; this staining technique recognises hepatic veins surrounded by GS-positive hepatocytes or the distal part of zone 3 if the central vein is not visible .
We sampled three representative sections of the nodule whole surface and non-tumoural surrounding tissue. The following stains and immunostains were performed on serial sections from 2 blocks: H&E, Masson's trichrome, cytokeratines (CK) 7 and 19, α-smooth muscle actin (SMA), and GS. Additional immunostaining included CD34 for characterising capillarised sinusoids, CRBP1 (cellular retinol binding protein-1) for hepatic stellate cells, CD3 and CD20 for T- and B-lymphocytes, respectively, and CD68 for histiocytes.
FNH is frequently observed in tertiary referral centres. The diagnosis is usually easy using imaging techniques, such as ultrasound contrast agents, or MRI. If imaging techniques or biopsies cannot exclude adenoma , a diagnosis can also be made using the resected specimen. We found the use of various immunohistochemical methods, including LFABP (cellular retinol binding protein), β-catenin, SAA (serum amyloid A) and GS , very useful for differentiating between FHN and adenoma in difficult cases.
Glutamine synthase, physiologically expressed in one or two hepatocyte plates located immediately beside the central veins in normal liver, is over-expressed in FNH with over-stained hepatocytes generally forming large areas; often anastomosed in a "map-like" pattern occasionally centred by central veins, whereas GS positive areas remain distant from fibrous bands. This zonal pattern of GS expression in FNH strongly differs from the homogeneous staining usually observed in adenomas and adenomas in which β-catenin is mutated .
Surprisingly, there is not much data in relation to FNH formation . In this case, the lobular structure was generally preserved in each of the sections studied, and we observed no ductular reaction and no fibrosis. Hepatic veins were identified from portal tracts with certainty, as a result of GS localization, and isolated arteries were visually detected well with α-SMA, thus providing a better understanding of FNH.
From this study, it is clear that in early stages of FNH formation there are various features: a) at the border, there were abnormal portal tracts, which were more fibrotic, and there was also an absence of portal veins and ducts and arterial proliferation, often in proximity with large draining veins; b) isolated arteries in the lesion; c) an absence or rarefaction of hepatic veins. All these features appeared prior the identification of other major characteristics of FNH, i.e., nodules circled by fibrous bands, ductular reaction, abnormal vessels and several arteries in fibrotic bands.
These observations support suggestions by Wanless et al.  and confirm that in FNH there is a portal tract injury leading to local PV injury. Wanless' group has suggested that the PV injury (from thrombosis or phlebitis) leads to a cascade of events, such as secondary large arterio-PV shunts. Arterio-PV shunts lead to the arterialisation of PV with irregular intimal thickening resembling a dystrophic artery. Wanless and colleagues have also suggested that duct loss is related to portal tract changes, and that the entry of enlarged arteries in the hepatic venous bed could be the consequence of congestive injury.
It is not possible to fully understand the pathogenesis of FNH from a single case. It is possible, however, from our current understanding of the role of the hepatic artery in the normal liver  to propose a direct role of this vessel in FNH formation.
In normal livers, the artery within the portal tract supplies three compartments: the peribiliary vascular plexus, the portal tract interstitium, and the portal vein wall. However, the artery outside the portal tract (termed isolated artery) supplies two compartments: the hepatic capsule and the hepatic vein wall .
The prime cause of FNH may be arterial, due to the lack of branches to various tributaries (portal, hepatic veins and ducts). This lack of branches may lead to conditions that are either primary (malformative focal arterial disease) or secondary to inflammation (as suggested by an increased number of inflammatory cells in portal tracts); this in turn leads to the disappearance of portal vein, bile ducts, and hepatic veins, subsequently resulting in the enlargement and proliferation of arteries, in venous shunts (portal and hepatic) and in all other features described by Wanless et al. . Disappearance of bile ducts may lead to cholestasis, and therefore to ductular reaction and fibrosis.
The aim of this study was not to confirm the presence of arterio-venous shunts (portal vein or hepatic vein). The existence of these shunts proposed by Wanless' group is however very likely (proximity of artery to hepatic vein, and dystrophic arterial vessels in portal tracts).
The suggestion of an arterial malformation is consistent with the possibility of discovering FNH during foetal life and in infancy, the stability of the lesions over time, the association with other vascular malformations, and the singular or multiple nature of nodules .
Our observations confirm that in FNH there is a portal tract injury defined by the disappearance of portal vein, bile ducts, and hepatic veins, subsequently leading to the enlargement and proliferation of arteries, and to venous shunts (portal and hepatic). The prime cause of FNH may be arterial.
Informed consent was obtained from the patient for publication of this case report.
- Bioulac-Sage P, Balabaud C, Bedossa P, Scoazec JY, Chiche L, Dhillon AP, Ferrell L, Paradis V, Roskams T, Vilgrain V, Wanless IR, Zucman-Rossi J: Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol. 2007, 46: 521-527. 10.1016/j.jhep.2006.12.007.View ArticlePubMedGoogle Scholar
- Terminology of nodular hepatocellular lesions. International Working Party. Hepatology. 1995, 22: 983-993.Google Scholar
- Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985, 5: 1194-1200. 10.1002/hep.1840050622.View ArticlePubMedGoogle Scholar
- Bioulac-Sage P, Balabaud C, Wanless IR: Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol. 2001, 25: 1322-1325. 10.1097/00000478-200110000-00015.View ArticlePubMedGoogle Scholar
- Wanless IR, Sapp H, Guindy M, Olshansky D, Takayama A: The pathogenesis of focal nodular hyperplasia/ an hypothesis based on histological review of 20 lesions including 3 occurring in early biliary cirrhosis. Hepatology. 2006, Suppl 1: 491A-Google Scholar
- Lepreux S, Laurent C, Balabaud C, Bioulac-Sage P: FNH-like nodules: Possible precursor lesions in patients with focal nodular hyperplasia (FNH). Comp Hepatol. 2003, 2: 7-10.1186/1476-5926-2-7.PubMed CentralView ArticlePubMedGoogle Scholar
- Gebhardt R, Baldysiak-Figiel A, Krugel V, Ueberham E, Gaunitz F: Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem. 2007, 41: 201-266. 10.1016/j.proghi.2006.12.001.View ArticlePubMedGoogle Scholar
- Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, Balabaud C, Zucman-Rossi J: Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007, 46: 740-748. 10.1002/hep.21743.View ArticlePubMedGoogle Scholar
- Ekataksin W, Kaneda K: Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. Semin Liver Dis. 1999, 19: 359-382.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.